Monitoring the Session

SB 90

Hall Bill Bars The State From Blocking Off-Label Prescriptions

Died in committee

Verdict: No flags

No flagsInitial review
Sen. Bob HallRSenate 2

Initial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade

Caption

relating to patient access to prescription drugs for off-label use.

Caption from analyzed text · version I.

Summary

The Medical Board can’t discipline off-label prescribing that meets the standard of care. Abortion-inducing drugs excluded.

The bill bars state officials, employees, and agents from stopping or restricting a Texas physician from prescribing, giving, or dispensing an FDA-approved drug for a use other than the one on its label. It covers physicians, their patients, and the Texas Medical Board, and it excludes abortion-inducing drugs. On the ground, the Medical Board cannot discipline a doctor's license only for off-label prescribing when the care meets the medical standard of care, and the bill says it creates no new lawsuits against drug makers or doctors.

Labels

Labels: ZOMBIE BILL. Died 2 times: 88R SB 426 by Sen. Paxton (Died in committee) and this bill (Died in committee). Checked against 88R only.DO-OVER. Reworked text of a bill filed before that died: 88R SB 426 by Sen. Paxton (Died in committee). Filed in 2 sessions, counting this one. Checked against 88R only.TRY NO. 2. Filed in 2 sessions: 88R and 89R. Checked against 88R only.NEVER GOT A HEARING. Filed Nov 12, 2024 and referred to the Senate Health & Human Services committee. No public hearing. The bill died.

Receipt

The receipt

89R-SB90 · 2024-11-12

SOLD BY

ITEM

relating to patient access to prescription drugs for off-label use.

WHAT IT DOES

The Medical Board can’t discipline off-label prescribing that meets the standard of care. Abortion-inducing drugs excluded.

The bill bars state officials, employees, and agents from stopping or restricting a Texas physician from prescribing, giving, or dispensing an FDA-approved drug for a use other than the one on its label. It covers physicians, their patients, and the Texas Medical Board, and it excludes abortion-inducing drugs. On the ground, the Medical Board cannot discipline a doctor's license only for off-label prescribing when the care meets the medical standard of care, and the bill says it creates no new lawsuits against drug makers or doctors.

CHARGES

[ ] NONE FOUND

TOTAL

No fiscal note in the loaded record.

HISTORY

  1. Received by the Secretary of the Senate
  2. Filed
  3. Read first time
  4. Referred to Health & Human Services
FILED UNDER

BIG PHARMA'S BILL

THE TEXT

“An official, employee, or agent of this state may not prohibit or restrict a physician from prescribing, administering, or dispensing for off-label use a prescription drug.”

Bill text, introduced version (I)

The bill works in the prescription-drug lane by stopping state officials from limiting doctors' off-label prescribing of FDA-approved drugs, which widens patient access rather than protecting a channel.

No flags

THANK YOU FOR CHECKING THE RECEIPT

CAMPAIGN PAID FOR BY

CAMPAIGN PAID FOR BY

Donors

Not tied to this bill.

Sources

The author's campaign account only. Own money and internal transfers are separate on the member page.

Derived itemized flow · Jul 1, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Texans for Lawsuit Reform PAC$135,000.00

Texans for Lawsuit Reform PAC

$135,000.00

Cash
$129,000.00
Paid by others
$6,000.00
Total
$135,000.00
polling $6,000.00

Also funds 124 other sitting lawmakers.

Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Sep 12, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100987789, 101010195, 101040645, 101069307, 101073278.

Texans United for a Conservative Majority PAC$116,000.00

Texans United for a Conservative Majority PAC

$116,000.00

Cash
$110,000.00
Paid by others
$6,000.00
Total
$116,000.00
polling $6,000.00

Also funds 30 other sitting lawmakers.

Derived recipient stock · Sep 3, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Jun 27, 2025 to Oct 5, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101010195, 101033131, 101073278.

Bryan Hughes Campaign$100,000.00

Bryan Hughes Campaign

$100,000.00

Cash
$100,000.00
Paid by others
$0.00
Total
$100,000.00

Also funds 0 other sitting lawmakers.

Derived recipient stock · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.

Name match, not a verified identity: normalized filed name and state.

Sources

Derived itemized flow · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101073278.

Money

Missing data does not establish zero giving. Display amounts are rounded.

×

Texans for Lawsuit Reform PAC

$135,000.00

Cash
$129,000.00
Paid by others
$6,000.00
Total
$135,000.00
polling $6,000.00

Also funds 124 other sitting lawmakers.

Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Sep 12, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 100987789, 101010195, 101040645, 101069307, 101073278.

×

Texans United for a Conservative Majority PAC

$116,000.00

Cash
$110,000.00
Paid by others
$6,000.00
Total
$116,000.00
polling $6,000.00

Also funds 30 other sitting lawmakers.

Derived recipient stock · Sep 3, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.

TEC account match.

Team
Sources

Derived itemized flow · Jun 27, 2025 to Oct 5, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101010195, 101033131, 101073278.

×

Bryan Hughes Campaign

$100,000.00

Cash
$100,000.00
Paid by others
$0.00
Total
$100,000.00

Also funds 0 other sitting lawmakers.

Derived recipient stock · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.

Name match, not a verified identity: normalized filed name and state.

Sources

Derived itemized flow · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.

Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.

Report IDs: 101073278.

Votes

No floor vote loaded for this bill.

Fiscal

No fiscal note in the loaded record.

How this was graded

Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.

FILED BEFORE

Filed 2 times: 88R and 89R. Checked against 88R only.

88R SB 426

by Sen. Paxton, different lead author · Died in committee · reworked

Introduced text

Last action, Apr 17, 2023: Referred to Public Health

Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

Caption, 88R bill history

Sources

Texas Senate · Filed Nov 12, 2024

02/03/2025 S Referred to Health & Human Services

Texas Legislature Online · Introduced

Data snapshot Oct 26, 2026 at 4:19 AM CDT. Grades, charges, quotes and corrections follow the published record.

Senate committee · Health & Human Services · Final status: Died in committee

Subjects

Health Care Providers

Health--General

Health--Other Diseases & Medical Conditions

MEDICINE & PRESCRIPTION DRUGS

PHYSICIANS

MEDICAL BOARD, TEXAS

Text

The text as introduced · 386 words

89R3375 EAS-D

By: Hall
S.B. No. 90

A BILL TO BE ENTITLED

AN ACT

relating to patient access to prescription drugs for off-label use.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. This Act shall be known as the Right to Treat

Act.

SECTION 2. Subtitle C, Title 6, Health and Safety Code, is

amended by adding Chapter 491 to read as follows:

CHAPTER 491. OFF-LABEL USE OF PRESCRIPTION DRUGS

Sec. 491.001. DEFINITIONS. In this chapter:

(1) "Off-label use" means the use of a prescription

drug approved for use by the United States Food and Drug

Administration in a manner other than the approved use.

(2) "Physician" means an individual licensed to

practice medicine in this state.

Sec. 491.002. APPLICABILITY. This chapter applies only to

the prescribing, administering, and dispensing of a prescription

drug the United States Food and Drug Administration has approved

for human use other than an abortion-inducing drug as defined by

Section 171.061.

Sec. 491.003. PROHIBITED STATE INTERFERENCE WITH PATIENT

ACCESS TO OFF-LABEL USE OF PRESCRIPTION DRUG. An official,

employee, or agent of this state may not prohibit or restrict a

physician from prescribing, administering, or dispensing for

off-label use a prescription drug.

Sec. 491.004. NO CAUSE OF ACTION CREATED. This chapter does

not create a private or state cause of action against a manufacturer

of a prescription drug approved by the United States Food and Drug

Administration or against a physician or any other person involved

in the care of a patient for any harm to the patient resulting from

the off-label use of the drug.

Sec. 491.005. PROHIBITED ACTION AGAINST PHYSICIAN'S

LICENSE. Notwithstanding any other law, the Texas Medical Board

may not revoke, fail to renew, suspend, or take any other adverse

action against a physician's license under Subchapter B, Chapter

164, Occupations Code, based solely on the physician's prescribing,

administering, or dispensing a prescription drug for off-label use

to treat a patient, provided the physician's treatment of the

patient meets the medical standard of care.

SECTION 3. This Act takes effect immediately if it receives

a vote of two-thirds of all the members elected to each house, as

provided by Section 39, Article III, Texas Constitution. If this

Act does not receive the vote necessary for immediate effect, this

Act takes effect September 1, 2025.